The results showed that the SNPs in IL5 might play a role in CAD by affecting the traditional risk factors for CAD and through SNP-SNP interactions, providing a new target for the specific treatment of CAD and a theoretical basis for personalized medicine. Here, IL5 is linked to coronary artery disorder.